The Global Metabolism Drugs Market Growth Accelerated By Increasing Prevalence Of Metabolic Disorders

Metabolism Drugs Market

 


Metabolism drugs help regulate various metabolic processes in the body such as fat and protein metabolism. They help manage conditions related to metabolism like diabetes, obesity, and amino acid metabolism disorders. The rising prevalence of metabolic disorders worldwide has accelerated the demand for these drugs.

The global Metabolism Drugs Market is estimated to be valued at US$ 8169.16 Mn in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:


The increasing prevalence of metabolic disorders is one of the key factors fueling the growth of the metabolism drugs market. As per the International Diabetes Foundation, in 2019 around 463 million adults aged between 20-79 years were living with diabetes worldwide and this number is expected to rise to 700 million by 2045. Obesity rates are also increasing rapidly globally. According to the World Obesity Federation, in 2016 around 2.2 billion adults were overweight or obese and around 340 million children and adolescents aged 5-19 were overweight or obese. Due to the rising metabolic health issues, the demand for safe and effective medications to treat these conditions is growing significantly. Leading to increased research and development activities in this market.


Segment Analysis


The global metabolism drugs market is dominated by the digestive enzymes segment, which accounted for more than 25% share of the market in 2023. Digestive enzymes help breakdown macromolecules such as proteins, carbohydrates, and fats into smaller molecules that can then be absorbed into the bloodstream. They play a key role in helping the body properly digest and absorb nutrients from food. The growing prevalence of digestive disorders such as pancreatitis and digestion related side effects of certain medications have boosted demand for digestive enzymes supplements in recent years.

Key Takeaways


The Global Metabolism Drugs Market Demand  is expected to witness high growth over the forecast period of 2023 to 2030. The global Metabolism Drugs Market is estimated to be valued at US$ 8169.16 Mn in 2023 and is expected to exhibit a CAGR of 7.6% over the forecast period 2023 to 2030.

Regional analysis indicates that North America currently dominates the global market, accounting for more than 30% share. Factors such as the increasing prevalence of obesity and diabetes, growing geriatric population, and strong presence of major players in the region have contributed to North America's large market share. The Asia Pacific region is expected to be the fastest growing market during the forecast period, owing to rising health awareness, increasing healthcare expenditure, and growing middle class affluence in countries such as China and India.

Key players related content
Key players operating in the metabolism drugs market are Central Admixture Pharmacy Services, Inc., Nephron Pharmaceuticals Corporation, QuVa Pharma, Olympia Pharmacy, ASP Cares, Fagron Compounding Pharmacies, Athenex, Inc., Avella Specialty Pharmacy, Atlas Pharmaceuticals, Empower Pharmacy, Carie Boyd€TMS Prescription Shop, Edge Pharma, Imprimis NJOF, LLC, IntegraDose Compounding services, LLC, Wells Pharma of Houston, LLC, US Compounding Inc., and SCA Pharma.

 

Explore more information on this topic, Please visit-   

https://www.marketwebjournal.com/metabolism-drugs-market-growth-and-trnds-analysis-share-size-demand-forecast/ 

Comments

Popular posts from this blog

Riding the Wave: Navigating Dynamics in the Windsurf Foil Board Market

Navigating Opportunities In The Niemann-Pick Disease Drug Type C Treatment Market

Automation of Agricultural Operations to Drive the Agricultural Drones Market Growth